ATLANTA (CN) — A federal appeals court on Monday rejected a pharmaceutical company’s motion for relief from a $40 million contempt judgement to the Federal Trade Commission for making repeated false ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback